Theriva Biologics
TOVX
TOVX
27 hedge funds and large institutions have $3.91M invested in Theriva Biologics in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
80% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 10
Holders
27
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$284K | |
| 2 | +$60.4K | |
| 3 | +$57.7K | |
| 4 |
Two Sigma Advisers
New York
|
+$20K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$14K |
Top Sellers
| 1 | -$507K | |
| 2 | -$393K | |
| 3 | -$302K | |
| 4 |
BlackRock
New York
|
-$284K |
| 5 |
VF
Virtu Financial
New York
|
-$131K |